KMT2A and acute lymphoblastic leukemia: Here, we demonstrate that prolonged exposure to low‐dose decitabine occasionally sensitizes MLL‐rearranged ALL cells to some of the current chemotherapeutics at certain concentrations in some of the cell lines tested.